Proposals related to finding a cure for a rare inherited retinal disease are due by March 31, 2024 CRF has funded approximately $5 million in research studies during

November 28, 2023, 17:44 GMT Luise de Lemos, PhD, Champalimaud Foundation Toma S. Aleman, MD, University of Pennsylvania Studies will explore new research areas that may provide more

September 07, 2023, 13:42 GMT Bhanu P. Telugu, PhD Mariya Moosajee, MBBS, BsC (Hons), PhD, FRCOphth SPRINGFIELD, MA, UNITED STATES, EINPresswire.com/ — The Choroideremia Research Foundation (CRF) is

October 19, 2023, 13:03 GMT New Members Join the Board of Directors Each of them brings important experiences from their accomplished professional lives that will enrich the thinking

Encinitas, California–(Newsfile Corp. – August 3, 2023) – Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), a clinical-stage ophthalmic pharmaceutical company developing novel therapeutics for patients with high unmet needs, and

June 20, 2023, 09:00 GMT Ian MacDonald, MD, CM Twin brothers have identical CHM mutation but one brother has no symptoms Dr. MacDonald’s research continues to explore promising

May 01, 2023, 00:00 GMT Dror Sharon, PhD, Hadassah-Hebrew University Medical Center Shay Ben Aroya, PhD, Bar-Ilan University Focus on ADAR-based RNA editing in the retina Drs. Sharon

March 23, 2023, 07:25 GMT CRF has funded approximately $5 million in research studies during its 23-year history. Research will focus on choroideremia nonsense mutations We are very

February 15, 2023, 17:09 GMT Sena Gocuk, recipient of The Benelli Family Research Award Research will identify the biomarker to predict disease progression We are very excited to

January 10, 2023, 12:00 GMT Members of the International Choroideremia Research Network Proposals related to finding a cure for a rare inherited retinal disease are due by March